Author:
Kuroda Ryosuke,Fukui Tomoaki,Ishida Kazunari,Sasaki Ken,Tabata Yasuhiko
Publisher
Japan Society of Drug Delivery System
Reference33 articles.
1. 1)Adesida AB, Grady LM, Khan WS, Hardingham TE. The matrix-forming phenotype of cultured human meniscus cells is enhanced after culture with fibroblast growth factor 2 and is further stimulated by hypoxia. Arthritis Res Ther. 2006;8(3):R61.
2. 2)Bhargava MM, Hidaka C, Hannafin JA, Doty S, Warren RF. Effects of hepatocyte growth factor and platelet-derived growth factor on the repair of meniscal defects in vitro. In Vitro Cell Dev Biol Anim. Sep-Oct 2005;41(8-9):305-310.
3. 3)Chan KA, Andrade SE, Boles M, et al. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet. Jun 24 2000;355(9222):2185-2188.
4. 4)Friedlaender GE. OP-1 clinical studies. J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 2):S160-161.
5. 5)Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 2):S151-158.